Re-Prealbumin: A New Biomarker for Predicting Prognosis in Patients with Severe COVID-19

dc.contributor.authorÖzdemir, Serdar
dc.contributor.authorKokulu, Kamil
dc.date.accessioned2022-01-20T05:13:10Z
dc.date.available2022-01-20T05:13:10Z
dc.date.issued2021
dc.departmentTıp Fakültesi
dc.description.abstract...
dc.identifier.doi10.29271/jcpsp.2021.Supp3.S163
dc.identifier.endpageS163en_US
dc.identifier.issn1022-386X
dc.identifier.issn1681-7168
dc.identifier.issue7en_US
dc.identifier.startpageS163en_US
dc.identifier.urihttps:/dx.doi.org/10.29271/jcpsp.2021.Supp3.S163
dc.identifier.urihttps://hdl.handle.net/20.500.12451/9140
dc.identifier.volume31en_US
dc.identifier.wosWOS:000721361700031
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherCollege Physicians and Surgeons Pakistan
dc.relation.ispartofJournal of the College of Physicians and Surgeons Pakistan
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectA New Biomarker for Predicting Prognosis
dc.subjectCOVID-19
dc.titleRe-Prealbumin: A New Biomarker for Predicting Prognosis in Patients with Severe COVID-19
dc.typeLetter

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: